Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report)'s stock price gapped down before the market opened on Monday . The stock had previously closed at $17.18, but opened at $16.03. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.06, with a volume of 8,957 shares trading hands.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on TLX. UBS Group lifted their target price on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a "buy" rating in a report on Monday, January 27th. William Blair reiterated an "outperform" rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Wednesday, March 12th.
Check Out Our Latest Stock Report on Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited American Depositary Shares Trading Up 2.6%
The business has a fifty day simple moving average of $16.98.
Hedge Funds Weigh In On Telix Pharmaceuticals Limited American Depositary Shares
An institutional investor recently bought a new position in Telix Pharmaceuticals Limited American Depositary Shares stock. ABC Arbitrage SA acquired a new position in Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The fund acquired 26,939 shares of the company's stock, valued at approximately $451,000.
Telix Pharmaceuticals Limited American Depositary Shares Company Profile
(
Get Free Report)
Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
See Also
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
